Researchers at UC Davis Health System have now begun to use new stem cell therapy from Mesoblast technology to promote bone tissue growth after the removal of cervical discs, according to a hospital news release.
Kee Kim, MD, and Rudolph Shrot, MD, are associate professors of neurosurgery at UC Davis who have performed the procedure. The surgery uses bone marrow-derived adult stem cells to promote bone tissue growth as part of a nationwide, multicenter clinical trial of the therapy.
The first procedure in the trial at UC Davis was recently performed in an anterior cervical discectomy. The stem cells were derived from a donor's bone marrow and grown in culture to a high concentration.
Related Articles on Spine Surgery:
What Factors Into the Employment Decision for Spine Surgeons? 6 Responses
Dr. John Caruso: Becoming a Champion of Change in Healthcare
Scoliosis as a Neurologic Condition: 4 Points on Two New Genes Making the Connection
The first procedure in the trial at UC Davis was recently performed in an anterior cervical discectomy. The stem cells were derived from a donor's bone marrow and grown in culture to a high concentration.
Related Articles on Spine Surgery:
What Factors Into the Employment Decision for Spine Surgeons? 6 Responses
Dr. John Caruso: Becoming a Champion of Change in Healthcare
Scoliosis as a Neurologic Condition: 4 Points on Two New Genes Making the Connection